Ankrin Therapeutics

Ankrin Therapeutics is a biotech start-up developing first-in-class drugs for cancer treatment. Our novel and unique therapeutic strategies, founded on forefront high quality research in cancer biology, target essential protein-protein interactions required for error-free DNA damage repair.

Contact name:

Rafel Simó Vicens (Project Coordinator)


Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 5150 0560

Copyright 2019 Danskbiotek. All rights reserved.